Sale!

BCAP31 Gene Deafness Dystonia and Cerebral Hypomyelination X-Linked Genetic Test

Original price was: $700.Current price is: $500.

-29%

The BCAP31 Gene Deafness Dystonia and Cerebral Hypomyelination X-Linked NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the BCAP31 gene responsible for a rare X-linked neurological disorder. This advanced next-generation sequencing test detects genetic abnormalities that cause progressive sensorineural hearing loss, movement disorders, and brain development issues. The test provides crucial information for accurate diagnosis, family planning, and personalized treatment approaches. For only $500 USD, patients receive detailed genetic analysis with results in 3-4 weeks using blood, extracted DNA, or FTA card samples. This test is essential for individuals with unexplained neurological symptoms, developmental delays, or family history of X-linked genetic disorders.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

BCAP31 Gene Deafness Dystonia and Cerebral Hypomyelination X-Linked NGS Genetic DNA Test

Comprehensive Genetic Testing for X-Linked Neurological Disorders

The BCAP31 Gene Deafness Dystonia and Cerebral Hypomyelination X-Linked NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying rare genetic disorders affecting neurological development and function. This specialized test utilizes next-generation sequencing technology to analyze the BCAP31 gene, which plays a critical role in protein transport and cellular function. Mutations in this X-linked gene can lead to complex neurological conditions characterized by progressive hearing loss, movement disorders, and impaired brain myelination.

What Does This Test Measure and Detect?

This comprehensive genetic analysis specifically targets the BCAP31 gene to identify pathogenic variants responsible for:

  • X-linked deafness-dystonia-optic neuropathy syndrome
  • Cerebral hypomyelination disorders
  • Progressive sensorineural hearing loss
  • Movement disorders including dystonia and ataxia
  • Developmental delays and intellectual disability
  • Optic nerve atrophy and visual impairment

Who Should Consider This Test?

This genetic test is recommended for individuals presenting with:

  • Unexplained progressive hearing loss, particularly in childhood
  • Movement disorders including dystonia, tremors, or coordination problems
  • Developmental delays or regression in motor skills
  • Family history of X-linked neurological disorders
  • Unexplained cerebral hypomyelination on brain imaging
  • Multiple neurological symptoms without clear diagnosis
  • Suspected genetic disorders affecting the nervous system

Clinical Benefits of BCAP31 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Provides definitive identification of BCAP31 gene mutations
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Family Planning: Offers crucial information for genetic counseling and reproductive decisions
  • Prognostic Insights: Helps predict disease progression and potential complications
  • Early Intervention: Facilitates timely management strategies for better outcomes
  • Research Contribution: Advances understanding of rare neurological disorders

Understanding Your Test Results

Our genetic counselors provide comprehensive interpretation of your BCAP31 gene test results:

  • Positive Result: Indicates the presence of a pathogenic mutation in the BCAP31 gene, confirming diagnosis of X-linked deafness-dystonia-cerebral hypomyelination syndrome
  • Negative Result: Suggests no detectable mutations in the BCAP31 gene, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact requiring further evaluation
  • Carrier Status: Determines if individuals carry the mutation without showing symptoms

Test Details and Pricing

Test Component Details
Test Name BCAP31 Gene Deafness Dystonia and Cerebral Hypomyelination X-Linked NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty ENT Doctor, Genetics

Pre-Test Requirements

Before scheduling your BCAP31 genetic test, please ensure:

  • Complete clinical history documentation
  • Genetic counseling session to discuss testing implications
  • Family pedigree chart creation for affected relatives
  • Understanding of potential outcomes and their significance
  • Informed consent for genetic testing procedures

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures consistent quality and reliable results nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about neurological symptoms affect your quality of life. Our BCAP31 genetic test provides the clarity needed for proper diagnosis and management. With our discounted price of only $500 USD, comprehensive genetic analysis is accessible and affordable. Our team of genetic specialists and ENT doctors are ready to guide you through the testing process and help interpret your results.

Ready to schedule your test? Call our genetic counseling team at +1(267) 388-9828 or book your appointment online today. Take the first step toward understanding your genetic health and receiving the personalized care you deserve.